News items Computer herkent kanker in weefselbeelden

13 December 2017

Artificially intelligent computer algorithms can equal human pathologists in detecting metastases of breast cancer in lymph nodes. This was demonstrated during the CAMELYON16 challenge of Radboud university medical center. In an article to be published in JAMA (Journal of the American Medical Association) on 12 December, researchers have shown for the first time that deep learning algorithms have sufficient quality to make routine diagnoses based on images of tissue preparations. The technique can help pathologists make better and faster diagnoses.

Between November 2015 and November 2016, researchers from Radboud university medical center organized the CAMELYON16 challenge. Machine learning researchers were given the opportunity to create a computer algorithm that can independently make a diagnosis based on pathology images. More specifically, this involved detecting metastases of breast cancer in lymph nodes. The challenge was accepted by 23 research groups from around the world, and the results have now been announced.
Identify metastases
Participants in CAMELYON16 were given 270 digital images of tissue preparations, of which it was already known whether, and where, metastases could be found. Using these images, the participants developed algorithms and trained these to detect the metastases. They then received 129 new images, which they used to test the algorithm. The algorithm had to distinguish between images with and without metastases, and then locate the exact position of the metastases.
Human pathologists
To compare the quality of the computer diagnoses with human performance, the 129 test images were also assessed by eleven experienced pathologists. They assessed the images of tissue preparations under conditions that were similar to a realistic hospital situation. In addition, one experienced pathologist was allowed to take as much time as she wanted to diagnose the images. 
Deep learning
The participating research groups submitted a total of 32 computer algorithms. The most successful algorithms used ‘deep learning’, in which the computer learns to recognize patterns based on a large number of examples. The winning algorithm detected metastases as effectively as the pathologist who worked without time pressure. On average, this algorithm generated a false positive (a metastasis that actually did not exist) only 1.25 times per hundred images. The top algorithms performed significantly better than the pathologists who assessed the images in the realistic hospital work situation.
Better and faster
Jeroen van der Laak, researcher at the Pathology department of Radboud university medical center, coordinated the challenge: “For the first time we have seen that a computer can make this diagnosis as effectively as a pathologist. A pathologist with this algorithm is therefore better off than a pathologist without.  The patient receives the result of the biopsy sooner, and the algorithm helps pathologists make better diagnoses, even under time pressure.” The researchers expect that the technique will be suitable for use in patient care within a few years, and that the computer algorithm will increasingly be capable of diagnoses.
  • Want to know more about these subjects? Click on the buttons below for more news.

    RIHSWomen's cancers

Related news items

Ioannis Sechopoulos receives NWO Vici grant for research on improving breast cancer diagnostics

1 March 2022 Ioannis Sechopoulos will conduct research into improving tomosynthesis, an X-ray examination that radiologists use to detect breast cancer. read more

Body composition is more important than BMI for renal cancer survival rates

11 January 2022 Body composition is important for survival rates in renal cell cancer. Research from the Radboudumc shows that low muscle quality and low organ fat are associated with poor survival. This involves different stages of renal cancer, ranging from stage I-III to stage IV. read more

1.4 million euro to reduce hospital admissions due to medication

7 January 2022 A team of sixteen Dutch hospitals received a grant of 1.4 million euros from ZonMw. They will investigate whether they can reduce medication related hospital readmissions. read more

A single comprehensive DNA test of a tumor is usually sufficient

25 August 2021 A one-time measurement of the entire tumor DNA is almost always sufficient to find all DNA errors that are important for treatment. read more

VIDI grants for researchers of Radboud university medical center

14 July 2021 Several Radboudumc researchers have been awarded a VIDI grant by the Dutch Organisation for Scientific Research (NWO). They each receive a sum of 800,000 euros, which they will use over the next five years to develop their own innovative line of research and to set up a research group. read more

2.5 million Euros for cancer research into ovarian cancer and immunotherapy

15 April 2021 The Radboudumc receives 2.5 million Euros from the Dutch Cancer Society (KWF) for three studies to ensure oncological progress during COVID-19 period. read more